OTCPK:CLVSF (Sweden)  
CellaVision AB logo

CellaVision AB

$ 22.46 0 (0%) 09:40 AM EST
P/E:
40.51
P/B:
8.40
Market Cap:
$ 494.93M
Enterprise V:
$ 499.07M
Volume:
-
Avg Vol (2M):
100.00
Also Trade In:
Volume:
-
Market Cap $:
494.93M
PE Ratio:
40.51
Avg Vol (2-Month):
100.00
Enterprise Value $:
499.07M
PB Ratio:
8.40
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
CellaVision AB is engaged in the business of supplying digital solutions for blood and body fluid analysis. Its solutions are based on digital image analysis technology, artificial intelligence, and information technology. The firm's product portfolio consists of CellaVision peripheral blood application, CellaVision advanced RBC application, and CellaVision remote review software. Its customers include mainly large hospital laboratories and commercial laboratories in North America, Europe and China, and Japan. The company derives the majority of its revenue from the sale of analyzers.

Financials (Next Earnings Date:2023-02-07)

CLVSF's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Gurus Latest Trades with OTCPK:CLVSF

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 66.261
EPS (TTM) ($) 0.546
Beta -0.12
Volatility % 25.6
14-Day RSI 0.04
14-Day ATR ($) 0.063966
20-Day SMA ($) 22.46
12-1 Month Momentum % -34.88
52-Week Range ($) 22.46 - 34.75
Shares Outstanding (Mil) 23.85

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

CellaVision AB Filings

Document Form Filing Date
No Filing Data

CellaVision AB Analysis

Share your research

Headlines

See More
No news.